CD79A and COVID-19: In previous studies, we have demonstrated a high-throughput SPRi assay for the quantitative measurement of IgM, IgG, and IgA antibodies and their apparent polyclonal affinity in the sera of COVID-19 patients in one single experiment with a run time of less than 30 min (20, 21).